Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000932471-25-000829·Cardiff Oncology, Inc.
Schedule 13G ownership disclosure
Cardiff Oncology Inc
Common Stock · CUSIP: 14147L108
Event date: 2025-06-30
- Filing-level shares
- 3,728,334
- Percent of class
- 5.60%
- The Vanguard Group
Shares: 3,728,334 · Class: 5.60%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000932471-25-000829
- Form type
- SCHEDULE 13G
- Filer
- Cardiff Oncology, Inc.
- CIK
- CIK 1213037
- Filed
- Jul 29, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership